Do immune-related adverse events correlate with response to immune checkpoint inhibitors?

Khalil Saleh; Nadine Khalife-Saleh; Hampig Raphael Kourie

doi:10.2217/imt-2018-0201

Do immune-related adverse events correlate with response to immune checkpoint inhibitors?

Khalil Saleh, Nadine Khalife-Saleh, Hampig Raphael Kourie

Résultats de recherche: Contribution à un journal › Article 'review' › Revue par des pairs

20 Citations (Scopus)

langue originale	Anglais
Pages (de - à)	257-259
Nombre de pages	3
journal	Immunotherapy
Volume	11
Numéro de publication	4
Les DOIs	https://doi.org/10.2217/imt-2018-0201
état	Publié - 1 mars 2019
Modification externe	Oui

Accès au document

10.2217/imt-2018-0201

Autres fichiers et liens

Lien vers la publication dans Scopus

Contient cette citation

@article{2c4f9e69111f408db90fdd7403c4363d,

title = "Do immune-related adverse events correlate with response to immune checkpoint inhibitors?",

keywords = "adverse events, atezolizumab, immune checkpoint inhibitors, immune-related, nivolumab, pembrolizumab",

author = "Khalil Saleh and Nadine Khalife-Saleh and Kourie, {Hampig Raphael}",

year = "2019",

month = mar,

day = "1",

doi = "10.2217/imt-2018-0201",

language = "English",

volume = "11",

pages = "257--259",

journal = "Immunotherapy",